SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 237 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $17,204,000 | -67.2% | 626,040 | -60.5% | 0.14% | -67.8% |
| Q2 2019 | $52,485,000 | -4.0% | 1,586,125 | +1.6% | 0.44% | -7.5% |
| Q1 2019 | $54,680,000 | +5.2% | 1,560,515 | -0.3% | 0.48% | -9.7% |
| Q4 2018 | $51,995,000 | -22.4% | 1,565,185 | +17.6% | 0.53% | -11.1% |
| Q3 2018 | $67,001,000 | -11.7% | 1,330,705 | +4.9% | 0.59% | -19.2% |
| Q2 2018 | $75,905,000 | +30.0% | 1,268,255 | -0.5% | 0.74% | +16.5% |
| Q1 2018 | $58,402,000 | +20.8% | 1,275,155 | +5.1% | 0.63% | +15.4% |
| Q4 2017 | $48,329,000 | -1.8% | 1,212,785 | -1.4% | 0.55% | -5.9% |
| Q3 2017 | $49,199,000 | +53.0% | 1,229,975 | +64.9% | 0.58% | +47.8% |
| Q2 2017 | $32,149,000 | – | 745,917 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |